Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 5)
Zdorovʹe Rebenka, 2018 The review of the literature presents modern data on antioxidant activity and immunomodulatory action of vitamin A in diseases of the respiratory system.
A.E. Abaturov +2 more
doaj +1 more source
New opportunities for inhaled therapy for inflammatory diseases of the respiratory system [PDF]
Терапевтический архив, 2017 The paper considers current approaches to mucoregulatory therapy for various inflammatory diseases of the respiratory system. It gives the advantages and disadvantages of common drugs used in their treatment.
G L Ignatova, V N Antonov
doaj +1 more source
Эпидемиология и вакцинопрофилактика, 2021 Relevance. Acute respiratory diseases (ARD) refer to mass infectious diseases, cause significant economic damage by provoking the development of diseases of the circulatory system, and the seasonal incidence of ARI is a predictor of mortality from ...
M. A. Papicheva, I. I. Yakushina
doaj +1 more source
Towards using Cough for Respiratory Disease Diagnosis by leveraging Artificial Intelligence: A Survey [PDF]
arXiv, 2023 Cough acoustics contain multitudes of vital information about pathomorphological alterations in the respiratory system. Reliable and accurate detection of cough events by investigating the underlying cough latent features and disease diagnosis can play an indispensable role in revitalizing the healthcare practices.
arxiv
Glucocorticoids and antibiotics, how do they get together? [PDF]
, 2015 Antibiotic therapy in patients currently treated with corticosteroids is common in chronic respiratory diseases when exacerbation symptoms attributable to infection appear. Among them, obstructive diseases such as asthma and chronic obstructive pulmonary
Monsó, Eduard, Reidl, Joachim
core +1 more source
Hospital admissions for respiratory system diseases in adults with intellectual disabilities in Southeast London:a register-based cohort study [PDF]
, 2017 BACKGROUND: Intellectual disability (ID) carries a high impact on need for care, health status and premature mortality. Respiratory system diseases contribute a major part of mortality among people with ID, but remain underinvestigated as consequent ...
Broadbent, Matthew +4 more
core +1 more source
Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier based Drug Delivery Systems. [PDF]
, 2020 Cell Signaling pathways form an integral part of our existence, that allows the cells to comprehend a stimulus and respond back. Such reactions, to external cues from the environment, are required and are essential to regulate the normal functioning of ...
Chellappan, DK +9 more
core +1 more source
FEBS Letters, EarlyView.Low‐density lipoprotein receptor‐related protein 6 (LRP6) is a key receptor for the Wnt antagonist Dickkopf1 (DKK1). DKK1 protein expression is induced in a bleomycin (BLM)‐induced lung injury model. We show that DKK1 induces proinflammatory and profibrotic genes in lung fibroblasts.
Eun‐Ah Sung +6 more
wiley +1 more source
VALUE OF RHEUMATIC PATIENTS' AWARENESS OF HAVING INFECTIOUS COMORBIDITIES
Современная ревматология, 2010 Subjects and methods. Four hundred and ninety-five patients with various RDs were interviewed by a questionnaire. A comparison group comprised 250 patients with non-RDs and 150 physicians. Results.
Rimma Mikhailovna Balabanova +3 more
doaj +1 more source
Role of Olive Bioactive Compounds in Respiratory Diseases
Antioxidants, 2023 Respiratory diseases recently became the leading cause of death worldwide, due to the emergence of COVID-19. The pathogenesis of respiratory diseases is centred around inflammation and oxidative stress.
Ubashini Vijakumaran +5 more
doaj +1 more source